4L52

Crystal Structure of 1-(4-{4-[7-amino-2-(1,2,3-benzothiadiazol-7-yl)furo[2,3-c]pyridin-4-yl]-1H-pyrazol-1-yl}piperidin-1-yl)ethan-1-one bound to TAK1-TAB1


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.54 Å
  • R-Value Free: 0.230 
  • R-Value Work: 0.195 
  • R-Value Observed: 0.196 

wwPDB Validation 3D Report Full Report


This is version 1.4 of the entry. See complete history


Literature

Discovery and optimization of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1.

Hornberger, K.R.Berger, D.M.Crew, A.P.Dong, H.Kleinberg, A.Li, A.H.Medeiros, M.R.Mulvihill, M.J.Siu, K.Tarrant, J.Wang, J.Weng, F.Wilde, V.L.Albertella, M.Bittner, M.Cooke, A.Gray, M.J.Maresca, P.May, E.Meyn, P.Peick, W.Romashko, D.Tanowitz, M.Tokar, B.

(2013) Bioorg Med Chem Lett 23: 4517-4522

  • DOI: 10.1016/j.bmcl.2013.06.053
  • Primary Citation of Related Structures:  
    4L3P, 4L52

  • PubMed Abstract: 
  • The discovery and potency optimization of a series of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1 is described. Micromolar hits taken from high-throughput screening were optimized for biochemical and cellular mechanistic potency to ~10nM, as exempl ...

    The discovery and potency optimization of a series of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1 is described. Micromolar hits taken from high-throughput screening were optimized for biochemical and cellular mechanistic potency to ~10nM, as exemplified by compound 12az. Application of structure-based drug design aided by co-crystal structures of TAK1 with inhibitors significantly shortened the number of iterations required for the optimization.


    Organizational Affiliation

    OSI Pharmaceuticals LLC, 1 Bioscience Park Drive, Farmingdale, NY 11735, USA. keith.hornberger@boehringer-ingelheim.com



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Mitogen-activated protein kinase kinase kinase 7, TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 chimeraA307Homo sapiensMutation(s): 0 
Gene Names: MAP3K7TAK1MAP3K7IP1TAB1
EC: 2.7.11.25
Find proteins for Q15750 (Homo sapiens)
Explore Q15750 
Go to UniProtKB:  Q15750
NIH Common Fund Data Resources
PHAROS  Q15750
Find proteins for O43318 (Homo sapiens)
Explore O43318 
Go to UniProtKB:  O43318
NIH Common Fund Data Resources
PHAROS  O43318
Protein Feature View
Expand
 ( Mouse scroll to zoom / Hold left click to move )
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
1UL
Query on 1UL

Download CCD File 
A
1-(4-{4-[7-amino-2-(1,2,3-benzothiadiazol-7-yl)furo[2,3-c]pyridin-4-yl]-1H-pyrazol-1-yl}piperidin-1-yl)ethanone
C23 H21 N7 O2 S
XDCWLOMVUOZXFY-UHFFFAOYSA-N
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
1ULIC50:  4   nM  BindingDB
1ULIC50 :  4   nM  PDBBind
1ULIC50:  12   nM  BindingDB
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.54 Å
  • R-Value Free: 0.230 
  • R-Value Work: 0.195 
  • R-Value Observed: 0.196 
  • Space Group: I 2 2 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 58.16α = 90
b = 133.784β = 90
c = 142.237γ = 90
Software Package:
Software NamePurpose
MOLREPphasing
REFMACrefinement
XDSdata reduction
XSCALEdata scaling

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2013-07-03
    Type: Initial release
  • Version 1.1: 2013-07-31
    Changes: Database references
  • Version 1.2: 2013-08-07
    Changes: Database references
  • Version 1.3: 2017-07-26
    Changes: Advisory, Refinement description, Source and taxonomy
  • Version 1.4: 2017-11-15
    Changes: Refinement description